Corrigendum to "The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors" [Pharmacol. Res. 147 (2019) 104392].
作者信息
Bechman Katie, Yates Mark, Galloway James B
机构信息
Centre for Rheumatic Diseases, Kings College London, United Kingdom.
Centre for Rheumatic Diseases, Kings College London, United Kingdom.
出版信息
Pharmacol Res. 2020 Mar;153:104634. doi: 10.1016/j.phrs.2020.104634. Epub 2020 Feb 1.
Abstract
摘要
相似文献
1
Corrigendum to "The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors" [Pharmacol. Res. 147 (2019) 104392].《治疗药物库中的新成员：小分子JAK抑制剂》[《药理学研究》147 (2019) 104392]的勘误
Pharmacol Res. 2020 Mar;153:104634. doi: 10.1016/j.phrs.2020.104634. Epub 2020 Feb 1.
2
Corrigendum to "Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty" [Pharmacol. Res. 128 (February) (2018) 345-358].《靶向NAD+降解：黄酮类化合物对阿尔茨海默病和认知功能减退的治疗潜力》的勘误[《药理学研究》128（2月）（2018年）345 - 358]
Pharmacol Res. 2018 Jun;132:242-244. doi: 10.1016/j.phrs.2018.03.007. Epub 2018 Mar 30.
3
Corrigendum to "Sugiol, a diterpenoid: Therapeutic actions and molecular pathways involved" Pharmacol. Res. 163 (2021) 105313.《“松香芹醇，一种二萜类化合物：治疗作用及相关分子途径”的勘误》，《药理学研究》第163卷（2021年），第105313页
Pharmacol Res. 2024 Jan;199:107044. doi: 10.1016/j.phrs.2023.107044. Epub 2023 Dec 22.
4
Corrigendum to "Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis" [Pharmacol. Res. 156 (June 2020) 104805].《代谢组学鉴定出用于胰腺癌精确诊断及相关组织转移的新生物标志物》的勘误[《药理学研究》156（2020年6月）104805]
Pharmacol Res. 2021 Jul;169:105657. doi: 10.1016/j.phrs.2021.105657. Epub 2021 May 18.
5
Corrigendum to "Guidelines for preparing color figures for everyone including the colorblind" [Pharmacol. Res. 119 (2017) 240-241].《为包括色盲者在内的所有人准备彩色图表的指南》勘误 [《药理学研究》119 (2017) 240 - 241]
Pharmacol Res. 2019 Jan;139:569. doi: 10.1016/j.phrs.2018.09.019. Epub 2018 Sep 29.
6
Corrigendum to "Obesity and hypertension" [Pharmacol. Res. 122 (2017) 1-7].《肥胖与高血压》的勘误[《药理学研究》122 (2017) 1 - 7]
Pharmacol Res. 2017 Oct;124:156. doi: 10.1016/j.phrs.2017.07.018. Epub 2017 Aug 1.
7
Corrigendum to "The role of STAG2 in bladder cancer" [Pharmacol. Res. 131 (2018) 143-149].《“STAG2在膀胱癌中的作用”的勘误》[《药理学研究》131 (2018) 143 - 149]
Pharmacol Res. 2019 Apr;142:315. doi: 10.1016/j.phrs.2019.02.023. Epub 2019 Mar 8.
8
Corrigendum to "Traditional Chinese medicine for COVID-19 treatment" [Pharmacol. Res. 155 (2020) 104743].《关于“用于治疗 COVID-19 的中药”的勘误》[《药理学研究》155 (2020) 104743]
Pharmacol Res. 2020 May;155:104768. doi: 10.1016/j.phrs.2020.104768. Epub 2020 Mar 25.
9
Corrigendum to "Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia" [Pharmacol. Res. 131 (2018) 66-74].《糖皮质激素损害社区获得性肺炎患者血小板血栓烷生物合成》的勘误 [《药理学研究》131 (2018) 66 - 74] 。
Pharmacol Res. 2018 Sep;135:268. doi: 10.1016/j.phrs.2018.07.008. Epub 2018 Jul 27.
10
Corrigendum to "The role of the LTB4-BLT1 axis in health and disease" [Pharmacol. Res. 158 (2020) 104857].《“白三烯B4-BLT1轴在健康与疾病中的作用”的勘误》[《药理学研究》158 (2020) 104857]
Pharmacol Res. 2020 Sep;159:105011. doi: 10.1016/j.phrs.2020.105011. Epub 2020 Jun 25.
引用本文的文献
1
Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents.轴性脊柱关节炎的潜在治疗选择：实验性药理药物概述
J Exp Pharmacol. 2021 Jul 2;13:627-635. doi: 10.2147/JEP.S262340. eCollection 2021.
2
Baricitinib for the treatment of rheumatoid arthritis.巴瑞替尼用于治疗类风湿性关节炎。
Reumatologia. 2020;58(6):407-415. doi: 10.5114/reum.2020.102006. Epub 2020 Dec 23.
Zotero 插件